Who To Treat, When To Treat And How To Treat Prostate Cancer: Generating Evidence To Guide Prostate Cancer Treatment Decisions
Funder
National Health and Medical Research Council
Funding Amount
$408,768.00
Summary
There is considerable uncertainty about which treatments lead to better outcomes for men with prostate cancer and whether treatment is always necessary. This project will compare different treatment options for prostate cancer, including active surveillance, to determine which offers the best chance of survival and least harm to men’s physical and mental wellbeing. It will also explore whether some men who do not receive active treatment (healthy older men) would benefit if they did.
Translating Gene Discovery For Key Diseases Into Clinical Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$772,490.00
Summary
The goal of the fellowship is capitalize on successful gene mapping studies for endometriosis, inflammatory bowel disease (IBD), melanoma and other complex diseases and conduct functional studies, cross-disease analyses, and genetic studies of response to treatment. These studies will identify specific genes responsible for increased disease risk to understand the biology of these diseases, their relationship with other diseases, and help improve disease management and clinical outcomes.
The Clinical Burden Of Campylobacter Infection In Australia
Funder
National Health and Medical Research Council
Funding Amount
$99,448.00
Summary
Campylobacter is a leading but less well recognised cause of gastroenteritis in Australia. This research seeks to better quantify and describe serious health outcomes resulting from Campylobacter infections by examining hospitalisations (including risk factors for admission) and estimating rates of death and long-term health problems following infection. The project will also examine the role GPs play in managing cases, particularly their use of antibiotics.
Identifying And Implementing Standardised Outcomes In Kidney Transplantation
Funder
National Health and Medical Research Council
Funding Amount
$274,076.00
Summary
The inconsistencies and lack of patient involvement in outcome selection for research can undermine shared decision-making and patient-centred care. Over three years, this global project will bring together patients,family members, healthcare providers, policy makers and industry to identify core outcomes in kidney transplantation. Implementation of the core outcome set will ensure that outcomes report in research are relevant, meaningful and important to patients with a kidney transplant.
Standardised Outcomes In Nephrology – Peritoneal Dialysis (SONG-PD): Establishing A Core Outcome Set In Peritoneal Dialysis
Funder
National Health and Medical Research Council
Funding Amount
$66,502.00
Summary
Standardised Outcomes in Nephrology-Peritoneal Dialysis study aims to establish a set of core outcomes for trials in PD based on the shared priorities of all stakeholders, so that outcomes of most relevance for decision making can be evaluated, and that interventions can be compared reliably.
Implications Of The Increasing Duration Of Life Spent With Obesity For Population Health
Funder
National Health and Medical Research Council
Funding Amount
$251,830.00
Summary
As the prevalence of obesity at younger ages increases, people are living longer with obesity. We have recently shown that this has an increased risk of mortality and diabetes. In this project we will look at the extent to which an increasing length of time lived with obesity is also associated with increased risks of hypertension, heart disease, cancer, arthritis and disability. We will also look at the effect of this increasing duration on the overall health of Australian adults.
Fundamental flaws in the design and reporting of research outcomes can undermine evidence-based medicine, impede patient-centred care, cause harm to patients, and result in a waste of research dollars. Our 3-year multinational project engages with patients, caregivers, clinicians, researchers and policy makers, to establish core outcomes in haemodialysis. This will ensure that patient-centred outcomes are consistently measured and reported in haemodialysis trials and other forms of research.